Asad Haider

Stock Analyst at Goldman Sachs

Total Price Targets

6

Stocks Covered

4

Sectors

Healthcare

Most Recent

Feb 4, 2026

Notable Calls (Last 12 Months)

Most Bullish

MRK+17.8%
Merck & Co., Inc.
$120.00 targetDec 2, 2025
MRK+14.8%
Merck & Co., Inc.
$133.00 targetFeb 4, 2026
JNJ+14.7%
Johnson & Johnson
$250.00 targetJan 22, 2026

Most Bearish

Stocks Covered by Asad Haider

Symbol	Company	Latest Target	Current Price	Upside	# Targets	Last Updated
MRK	Merck & Co., Inc.	$133.00	$111.89	+18.9%	2	Feb 4, 2026
ABBV	AbbVie Inc.	$223.00	$206.29	+8.1%	1	Jan 28, 2026
JNJ	Johnson & Johnson	$250.00	$227.97	+9.7%	2	Jan 22, 2026
PFE	Pfizer Inc.	$26.00	$26.38	-1.4%	1	Nov 5, 2025

Recent Activity

Feb 4, 2026— Set$133.00price target onMRK(Merck & Co., Inc.)
Jan 28, 2026— Set$223.00price target onABBV(AbbVie Inc.)
Jan 22, 2026— Set$250.00price target onJNJ(Johnson & Johnson)
Dec 18, 2025— Set$240.00price target onJNJ(Johnson & Johnson)
Dec 2, 2025— Set$120.00price target onMRK(Merck & Co., Inc.)
Nov 5, 2025— Set$26.00price target onPFE(Pfizer Inc.)

Frequently Asked Questions

Who is Asad Haider?

Asad Haider is a stock analyst at Goldman Sachs covering 4 stocks primarily in Healthcare. They have issued 6 price targets since Nov 5, 2025.

What stocks does Asad Haider cover?

Asad Haider currently covers 4 stocks, including MRK, JNJ, ABBV, PFE.

What is Asad Haider's latest price target?

Asad Haider's most recent price target was $133.00 on MRK (Merck & Co., Inc.), set on Feb 4, 2026.

What is Asad Haider's highest price target?

Asad Haider's highest issued price target is $250.00 on JNJ, set on Jan 22, 2026.

More Analysts at Goldman Sachs

Coverage based on publicly published price targets. Not investment advice.